LUC7L2 and acute myeloid leukemia: Depletion of LUC7L2 loci is more prevalent in high-risk MDS than in low-risk MDS, and low LUC7L2 expression correlates with significantly shorter survival in primary acute myeloid leukemia (pAML) patients [31].